BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06627647-completion@plaintrial.com
DTSTAMP:20261027T155345Z
DTSTART;VALUE=DATE:20300325
SUMMARY:A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Che
 motherapy for First-Line Treatment of Metastatic Non-squamous NSCLC — es
 timated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06627647
URL:https://plaintrial.com/trial/NCT06627647
END:VEVENT
END:VCALENDAR